Dr Thomas Langworthy Luzier, MD | |
201 S Lloyd St Ste W110, Aberdeen, SD 57401-4512 | |
(605) 225-0025 | |
(605) 225-2259 |
Full Name | Dr Thomas Langworthy Luzier |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 50 Years |
Location | 201 S Lloyd St Ste W110, Aberdeen, South Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578595096 | NPI | - | NPPES |
460422877 | Other | SD | FEDERAL TAX ID |
15845 | Medicaid | ND | |
59-00210 | Medicaid | SD | |
DQ7592 | Other | SD | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | SD1359 (South Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Avera St Lukes | Aberdeen, SD | Hospital |
Entity Name | Aberdeen Asthma & Allergy Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578882387 PECOS PAC ID: 7719018944 Enrollment ID: O20100701000327 |
News Archive
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor, a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme.
The need of systemic change in health care has been well recognized in most Western Countries. The key drivers of change relate to population ageing, technological development, changing expectations towards services and the political strive to put a damper on the growth of the GDP share of health expenditure. The publication sheds light on challenges in management of systemic innovation.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
Michael Clemens, a senior fellow at the Center for Global Development (CGD), addresses a recent New York Times article on "medical brain drain" in this CGD "Global Development: Views From The Center" blog post, saying the article's approval of "a horrific proposal to put recruiters of health workers on trial in The Hague for crimes against humanity ... is breathtakingly misguided."
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Langworthy Luzier, MD 201 S Lloyd St Ste W110, Aberdeen, SD 57401-4512 Ph: (605) 225-0025 | Dr Thomas Langworthy Luzier, MD 201 S Lloyd St Ste W110, Aberdeen, SD 57401-4512 Ph: (605) 225-0025 |
News Archive
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor, a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme.
The need of systemic change in health care has been well recognized in most Western Countries. The key drivers of change relate to population ageing, technological development, changing expectations towards services and the political strive to put a damper on the growth of the GDP share of health expenditure. The publication sheds light on challenges in management of systemic innovation.
Cardium Therapeutics today announced that it has entered into an agreement with bioRASI, an international contract research organization, to assist Cardium in the evaluation of Generx clinical development opportunities within major newly-industrializing markets in Eastern Europe, Asia and Latin America, for patients with chronic coronary artery disease who are either not optimal candidates for or do not have access to costly angioplasty/stenting or cardiac bypass surgery procedures.
Michael Clemens, a senior fellow at the Center for Global Development (CGD), addresses a recent New York Times article on "medical brain drain" in this CGD "Global Development: Views From The Center" blog post, saying the article's approval of "a horrific proposal to put recruiters of health workers on trial in The Hague for crimes against humanity ... is breathtakingly misguided."
› Verified 6 days ago